Victoria L. Dunne

Belfast, NIR, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Impact of ataxia-telangiectasia mutated (ATM) loss on radiobiological and immune response to radium-223 in prostate cancer in vitro models.

Impact of ataxia-telangiectasia mutated (ATM) loss on radiobiological and immune response to radium-223 in prostate cancer in vitro models.

Journal: Clinical and translational radiation oncology

Published: February 12, 2026

Cytotoxicity and cell cycle changes in prostate cancer cells with differing PSMA expression and p53 status after treatment with PSMA-targeting radioligand [212Pb]Pb-AB001.

Cytotoxicity and cell cycle changes in prostate cancer cells with differing PSMA expression and p53 status after treatment with PSMA-targeting radioligand [212Pb]Pb-AB001.

Journal: Scientific reports

Published: July 11, 2025

PTEN Depletion Increases Radiosensitivity in Response to Ataxia Telangiectasia-Related-3 (ATR) Inhibition in Non-Small Cell Lung Cancer (NSCLC).

PTEN Depletion Increases Radiosensitivity in Response to Ataxia Telangiectasia-Related-3 (ATR) Inhibition in Non-Small Cell Lung Cancer (NSCLC).

Journal: International journal of molecular sciences

Published: May 23, 2024

Synergistic Activity of DNA Damage Response Inhibitors in Combination with Radium-223 in Prostate Cancer.

Synergistic Activity of DNA Damage Response Inhibitors in Combination with Radium-223 in Prostate Cancer.

Journal: Cancers

Published: February 28, 2024

Differential responses to 223Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastrophe.

Differential responses to 223Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastrophe.

Journal: Frontiers in oncology

Published: February 16, 2022

Abiraterone In Vitro Is Superior to Enzalutamide in Response to Ionizing Radiation.

Abiraterone In Vitro Is Superior to Enzalutamide in Response to Ionizing Radiation.

Journal: Frontiers in oncology

Published: April 26, 2021

ATM Kinase Inhibition Preferentially Sensitises PTEN-Deficient Prostate Tumour Cells to Ionising Radiation.

ATM Kinase Inhibition Preferentially Sensitises PTEN-Deficient Prostate Tumour Cells to Ionising Radiation.

Journal: Cancers

Published: November 16, 2020

Impact of superparamagnetic iron oxide nanoparticles on in vitro and in vivo radiosensitisation of cancer cells.

Impact of superparamagnetic iron oxide nanoparticles on in vitro and in vivo radiosensitisation of cancer cells.

Journal: Radiation oncology (London, England)

Published: August 11, 2020

Preclinical models of radiation-induced lung damage: challenges and opportunities for small animal radiotherapy.

Preclinical models of radiation-induced lung damage: challenges and opportunities for small animal radiotherapy.

Journal: The British journal of radiology

Published: January 18, 2019

Preclinical Evaluation of Dose-Volume Effects and Lung Toxicity Occurring In and Out-of-Field.

Preclinical Evaluation of Dose-Volume Effects and Lung Toxicity Occurring In and Out-of-Field.

Journal: International journal of radiation oncology, biology, physics

Published: December 09, 2017

Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy.

Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 30, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026